The expression of OX40/OX40L in atopic dermatitis.

The expression of OX40/OX40L in atopic dermatitis. - OX40/OX40L in atopische dermatitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON46788

Enrollment

Registered

2017-10-09

Start date

2018-03-05

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with moderate to severe atopische dermatitis

Exclusion criteria

Exclusion criteria: Volunteers undergoing UV/light therapy or taking systemic drugs such as cyclosporin A or methotrexate Volunteers using local topical corticosteroids Volunteers developing Köbner phenomenon at wound sites

Design outcomes

Primary

Measure	Time frame
OX40/OX40L expression	—

Secondary

Measure	Time frame
-	—

Countries

Netherlands

Outcome results